Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-14-001013
Filing Date
2014-02-20
Accepted
2014-02-19 18:23:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT f424b30214_actinium.htm 424B3 2718554
  Complete submission text file 0001213900-14-001013.txt   2719598
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-193714 | Film No.: 14627216
SIC: 6770 Blank Checks